Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil

EP VanPuijenbroek*, PWG DuBufVereijken, PFMJ Spooren, JJ VanDoormaal

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

63 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Chemistry

Biochemistry, Genetics and Molecular Biology

Keyphrases